Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function

Cell Reports

Volumn 16, Issue 5, 2016, Pages 1339-1351

  Du, Fang ^a,c   Garg, Abhishek V ^a   Kosar, Karis ^a   Majumder, Saikat ^a   Kugler, David G ^b   Mir, Gerard Hernandez ^a   Maggio, Maria ^a   Henkel, Matthew ^a   Lacy Hulbert, Adam ^b   McGeachy, Mandy J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CD51 ANTIGEN; CILENGITIDE; INTERLEUKIN 23; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; IMMUNOLOGY; INFLAMMATION; TH1 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; INTEGRIN ALPHAVBETA3; INTERLEUKIN-23; MICE; MICE, INBRED C57BL; TH1 CELLS; TH17 CELLS;

EID: 84989828372     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.06.065     Document Type: Article

References (53)

1. Acharya, M., Mukhopadhyay, S., Païdassi, H., Jamil, T., Chow, C., Kissler, S., Stuart, L.M., Hynes, R.O., Lacy-Hulbert, A., αv Integrin expression by DCs is required for Th17 cell differentiation and development of experimental autoimmune encephalomyelitis in mice. J. Clin. Invest. 120 (2010), 4445–4452.
2. Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J., Gurney, A.L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003), 1910–1914.
3. Aly, L., Yousef, S., Schippling, S., Jelcic, I., Breiden, P., Matschke, J., Schulz, R., Bofill-Mas, S., Jones, L., Demina, V., et al. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain 134 (2011), 2687–2702.
4. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006), 235–238.
5. Cañete, J.D., Pablos, J.L., Sanmartí, R., Mallofré, C., Marsal, S., Maymó, J., Gratacós, J., Mezquita, J., Mezquita, C., Cid, M.C., Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum. 50 (2004), 1636–1641.
6. Chen, Y., Haines, C.J., Gutcher, I., Hochweller, K., Blumenschein, W.M., McClanahan, T., Hämmerling, G., Li, M.O., Cua, D.J., McGeachy, M.J., Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34 (2011), 409–421.
7. Chung, Y., Chang, S.H., Martinez, G.J., Yang, X.O., Nurieva, R., Kang, H.S., Ma, L., Watowich, S.S., Jetten, A.M., Tian, Q., Dong, C., Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30 (2009), 576–587.
8. Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., Becher, B., RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12 (2011), 560–567.
9. Courter, D.L., Lomas, L., Scatena, M., Giachelli, C.M., Src kinase activity is required for integrin alphaVbeta3-mediated activation of nuclear factor-kappaB. J. Biol. Chem. 280 (2005), 12145–12151.
10. Cua, D.J., Sherlock, J., Chen, Y., Murphy, C.A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003), 744–748.
11. Diao, H., Liu, X., Wu, Z., Kang, L., Cui, G., Morimoto, J., Denhardt, D.T., Rittling, S., Iwakura, Y., Uede, T., Li, L., Osteopontin regulates interleukin-17 production in hepatitis. Cytokine 60 (2012), 129–137.
12. Doucey, M.A., Legler, D.F., Faroudi, M., Boucheron, N., Baumgaertner, P., Naeher, D., Cebecauer, M., Hudrisier, D., Rüegg, C., Palmer, E., et al. The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. J. Biol. Chem. 278 (2003), 26983–26991.
13. Duhen, R., Glatigny, S., Arbelaez, C.A., Blair, T.C., Oukka, M., Bettelli, E., Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet. J. Immunol. 190 (2013), 4478–4482.
14. El Azreq, M.A., Boisvert, M., Cesaro, A., Pagé, N., Loubaki, L., Allaeys, I., Chakir, J., Poubelle, P.E., Tessier, P.A., Aoudjit, F., α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis. J. Immunol. 191 (2013), 5941–5950.
15. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.X., Dittel, B.N., Rostami, A., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12 (2011), 568–575.
16. Gagliani, N., Amezcua Vesely, M.C., Iseppon, A., Brockmann, L., Xu, H., Palm, N.W., de Zoete, M.R., Licona-Limón, P., Paiva, R.S., Ching, T., et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523 (2015), 221–225.
17. Garg, A.V., Amatya, N., Chen, K., Cruz, J.A., Grover, P., Whibley, N., Conti, H.R., Hernandez Mir, G., Sirakova, T., Childs, E.C., et al. MCPIP1 endoribonuclease activity negatively regulates interleukin-17-mediated signaling and inflammation. Immunity 43 (2015), 475–487.
18. Ghoreschi, K., Laurence, A., Yang, X.P., Tato, C.M., McGeachy, M.J., Konkel, J.E., Ramos, H.L., Wei, L., Davidson, T.S., Bouladoux, N., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 467 (2010), 967–971.
19. Glatigny, S., Duhen, R., Oukka, M., Bettelli, E., Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells. J. Immunol. 187 (2011), 6176–6179.
20. Goedkoop, A.Y., Kraan, M.C., Picavet, D.I., de Rie, M.A., Teunissen, M.B., Bos, J.D., Tak, P.P., Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res. Ther. 6 (2004), R326–R334.
21. Goverman, J., Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9 (2009), 393–407.
22. Haines, C.J., Chen, Y., Blumenschein, W.M., Jain, R., Chang, C., Joyce-Shaikh, B., Porth, K., Boniface, K., Mattson, J., Basham, B., et al. Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23. Cell Rep. 3 (2013), 1378–1388.
23. Han, M.H., Hwang, S.I., Roy, D.B., Lundgren, D.H., Price, J.V., Ousman, S.S., Fernald, G.H., Gerlitz, B., Robinson, W.H., Baranzini, S.E., et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451 (2008), 1076–1081.
24. Hellwig, K., Gold, R., Progressive multifocal leukoencephalopathy and natalizumab. J. Neurol. 258 (2011), 1920–1928.
25. Hirota, K., Duarte, J.H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D.J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12 (2011), 255–263.
26. Hur, E.M., Youssef, S., Haws, M.E., Zhang, S.Y., Sobel, R.A., Steinman, L., Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8 (2007), 74–83.
27. Hynes, R.O., Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002), 673–687.
28. Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., Cua, D.J., Littman, D.R., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006), 1121–1133.
29. Jäger, A., Dardalhon, V., Sobel, R.A., Bettelli, E., Kuchroo, V.K., Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183 (2009), 7169–7177.
30. Kurohori, Y., Sato, K., Suzuki, S., Kashiwazaki, S., Adhesion molecule expression on peripheral blood mononuclear cells in rheumatoid arthritis: positive correlation between the proportion of L-selectin and disease activity. Clin. Rheumatol. 14 (1995), 335–341.
31. Lacy-Hulbert, A., Ueno, T., Ito, T., Jurewicz, M., Izawa, A., Smith, R.N., Chase, C.M., Tanaka, K., Fiorina, P., Russell, P.S., et al. Beta 3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection. Am. J. Transplant. 7 (2007), 1080–1090.
32. Ma, E.A., Lou, O., Berg, N.N., Ostergaard, H.L., Cytotoxic T lymphocytes express a beta3 integrin which can induce the phosphorylation of focal adhesion kinase and the related PYK-2. Eur. J. Immunol. 27 (1997), 329–335.
33. Mangan, P.R., Harrington, L.E., O'Quinn, D.B., Helms, W.S., Bullard, D.C., Elson, C.O., Hatton, R.D., Wahl, S.M., Schoeb, T.R., Weaver, C.T., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006), 231–234.
34. Mas-Moruno, C., Rechenmacher, F., Kessler, H., Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer. Agents Med. Chem. 10 (2010), 753–768.
35. McCarty, J.H., Cook, A.A., Hynes, R.O., An interaction between alphavbeta8 integrin and Band 4.1B via a highly conserved region of the Band 4.1 C-terminal domain. Proc. Natl. Acad. Sci. USA 102 (2005), 13479–13483.
36. McGeachy, M.J., Bak-Jensen, K.S., Chen, Y., Tato, C.M., Blumenschein, W., McClanahan, T., Cua, D.J., TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8 (2007), 1390–1397.
37. McGeachy, M.J., Chen, Y., Tato, C.M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W.M., McClanahan, T.K., O'Shea, J.J., Cua, D.J., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10 (2009), 314–324.
38. Murugaiyan, G., Mittal, A., Weiner, H.L., Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 181 (2008), 7480–7488.
39. Oppmann, B., Lesley, R., Blom, B., Timans, J.C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000), 715–725.
40. + T cells is dependent on integrin αV. Nat. Immunol. 14 (2013), 949–958.
41. Ransohoff, R.M., Kivisäkk, P., Kidd, G., Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3 (2003), 569–581.
42. Reardon, D.A., Nabors, L.B., Stupp, R., Mikkelsen, T., Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme. Expert Opin. Investig. Drugs 17 (2008), 1225–1235.
43. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., Sallusto, F., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10 (2009), 514–523.
44. Rothhammer, V., Heink, S., Petermann, F., Srivastava, R., Claussen, M.C., Hemmer, B., Korn, T., Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J. Exp. Med. 208 (2011), 2465–2476.
45. Roy, A., Liu, X., Pahan, K., Myelin basic protein-primed T cells induce neurotrophins in glial cells via alphavbeta3 [corrected] integrin. J. Biol. Chem. 282 (2007), 32222–32232.
46. Sallusto, F., Impellizzieri, D., Basso, C., Laroni, A., Uccelli, A., Lanzavecchia, A., Engelhardt, B., T-cell trafficking in the central nervous system. Immunol. Rev. 248 (2012), 216–227.
47. Scatena, M., Almeida, M., Chaisson, M.L., Fausto, N., Nicosia, R.F., Giachelli, C.M., NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J. Cell Biol. 141 (1998), 1083–1093.
48. Steinman, L., New targets for treatment of multiple sclerosis. J. Neurol. Sci. 274 (2008), 1–4.
49. Steinman, L., Shifting therapeutic attention in MS to osteopontin, type 1 and type 2 IFN. Eur. J. Immunol. 39 (2009), 2358–2360.
50. Teesalu, T., Hinkkanen, A.E., Vaheri, A., Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am. J. Pathol. 159 (2001), 2227–2237.
51. Veldhoen, M., Hocking, R.J., Flavell, R.A., Stockinger, B., Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7 (2006), 1151–1156.
52. Zhou, L., Ivanov, I.I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D.E., Leonard, W.J., Littman, D.R., IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8 (2007), 967–974.
53. Zúñiga, L.A., Jain, R., Haines, C., Cua, D.J., Th17 cell development: from the cradle to the grave. Immunol. Rev. 252 (2013), 78–88.